申请人:Huang Liming
公开号:US20120035194A1
公开(公告)日:2012-02-09
The present invention relates to compounds of formula (I),
or a pharmaceutically acceptable salt or solvate thereof, wherein: R
1
, R
2
, Z
1
, t, and ring A are as defined in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a condition that is mediated by the modulation of JNK, such as diabetes, the method comprising administering to a mammal an effective amount of a compound of formula (I).
本发明涉及公式(I)的化合物,或其药学上可接受的盐或溶剂,其中:R1、R2、Z1、t和环A的定义如规范中所述。本发明还涉及包含公式(I)化合物的制药组合物以及治疗通过调节JNK介导的疾病的方法,例如糖尿病,该方法包括向哺乳动物施用公式(I)化合物的有效量。